Tevogen Bio Holdings, Inc. (TVGN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$7.34+2.37%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · TVGN
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
A comparable price-assumption read is not available for this company.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Worth watching into the next print: this name has erratic recent earnings surprises and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 398 industry peers · Company calendar date is not available
TVGN — officer change
Dated 2026-08-26
Director: The filing describes the holding of an annual meeting of stockholders, which typically involves the routine election of directors rather than a sudden executive departure.
Why it matters: Addressing compliance issues is crucial for staying listed on Nasdaq. Failure to comply could lead to delisting.
Worry ifManagement shares a plan to fix Nasdaq compliance issues.
Less concerning ifNo updates or worse compliance status are reported.
Why it matters: A drop in sector revenue growth could signal broader challenges for Tevogen.
Worry ifSector revenue growth is below its usual average.
Less concerning ifSector revenue growth is above its usual average.
Why it matters: Meeting these goals may lead to a special dividend. This can affect investor feelings.
Supportive ifTevogen says it has met financial goals needed for a special dividend.
Worry ifTevogen does not meet financial goals, which may delay or cancel the special dividend.
Why it matters: Meeting these goals could lead to a special dividend. This would increase shareholder value.
Supportive ifA report shows net income is positive or shows big steps toward making money.
Worry ifOngoing net losses with no signs of better financial performance.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$428 on $10,000 · ±4.3% | How much price usually moves either way. |
| Bad day | $1,098 loss on $10,000 · 11.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,121 loss on $10,000 · 91.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Earnings results will provide insights into financial health and future guidance. This could impact stock sentiment.
Watch forEarnings report shows revenue growth or positive guidance.
Also watch forEarnings report shows losses or bad guidance.
Why it matters: Fixing compliance issues is important to keep the company's stock listing.
Worry ifThe company gets confirmation from Nasdaq that it meets compliance rules.
Less concerning ifNasdaq warns or sends a delisting notice due to ongoing compliance problems.
Why it matters: Hitting financial goals may lead to a special dividend. This impacts shareholder value.
Supportive ifThe company says it has reached some financial goals for a special dividend.
Worry ifThere is no news about milestones or delays in reaching them.
Why it matters: Meeting financial goals may lead to a special dividend. This is important for investors.
Supportive ifTevogen says it hit key financial goals in its Q3 earnings.
Worry ifTevogen fails to meet any of the financial milestones set for Q3.
Why it matters: Tevogen received a notice for not meeting the $50 million market value. This could lead to delisting.
Worry ifA press release shows the company meets the $50 million market value requirement.
Less concerning ifMore Nasdaq notices show that the company is still not following rules.